Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human G M1 -Gangliosidosis
G -gangliosidosis is caused by a reduced activity of β-galactosidase ( ), resulting in intralysosomal accumulations of G . The aim of this study was to reveal the pathogenic mechanisms of G -gangliosidosis in a new knockout mouse model. mice were analyzed clinically, histologically, immunohistochemi...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2020-04, Vol.9 (4) |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | G
-gangliosidosis is caused by a reduced activity of β-galactosidase (
), resulting in intralysosomal accumulations of G
. The aim of this study was to reveal the pathogenic mechanisms of G
-gangliosidosis in a new
knockout mouse model.
mice were analyzed clinically, histologically, immunohistochemically, electrophysiologically and biochemically. Morphological lesions in the central nervous system were already observed in two-month-old mice, whereas functional deficits, including ataxia and tremor, did not start before 3.5-months of age. This was most likely due to a reduced membrane resistance as a compensatory mechanism. Swollen neurons exhibited intralysosomal storage of lipids extending into axons and amyloid precursor protein positive spheroids. Additionally, axons showed a higher kinesin and lower dynein immunoreactivity compared to wildtype controls.
mice also demonstrated loss of phosphorylated neurofilament positive axons and a mild increase in non-phosphorylated neurofilament positive axons. Moreover, marked astrogliosis and microgliosis were found, but no demyelination. In addition to the main storage material G
, G
, sphingomyelin, phosphatidylcholine and phosphatidylserine were elevated in the brain. In summary, the current
mice exhibit a so far undescribed axonopathy and a reduced membrane resistance to compensate the functional effects of structural changes. They can be used for detailed examinations of axon-glial interactions and therapy trials of lysosomal storage diseases. |
---|---|
ISSN: | 2077-0383 2077-0383 |